This work provides the structural basis for the use of EgB4 as a research tool, for targeting of drugs such as nanobody-drug conjugates, and as biomarker to monitor EGFR expression in tissues and tumor imaging, while not affecting EGFR function. Here, EGFR is linked to neoplasm.